SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K, dated October 12, 2011, reports on the adjourned 2011 Annual Meeting of Shareholders for India Globalization Capital, Inc. The meeting was reconvened on September 26, 2011, and again on October 12, 2011, to address a specific shareholder proposal regarding equity issuance.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
The primary matter submitted was Proposal 3: Approval of the issuance of up to 5,000,000 shares of common stock to the Steven M. Oliveira 1998 Charitable Remainder Unitrust under a March 24, 2011 agreement. The proposal failed to achieve the necessary approval threshold across three voting dates:
- August 25, 2011: 6,617,817 votes for (31.57% of outstanding shares).
- September 26, 2011: 6,649,704 votes for (31.73% of outstanding shares).
- October 12, 2011: 9,977,166 votes for (47.6% of outstanding shares) vs. 645,135 votes against.
Despite the increase in support, the issuance was not approved due to insufficient votes and a substantial number of broker non-votes.
Outlook and Management Commentary
Due to the failure to approve the stock issuance, the Company proposed and the stockholders present unanimously approved to adjourn and reconvene the meeting on Monday, October 28, 2011, at 10:00 AM. The stated purpose is to allow additional time to solicit proxies from shareholders who had not yet voted on Proposal 3.
Investor Verification Checklist
- Verify the outcome of the reconvened meeting scheduled for October 28, 2011.
- Confirm the total number of outstanding shares to validate the percentage calculations provided.
- Review the terms of the March 24, 2011 Note and Share Purchase Agreement to understand the implications of the proposed 5,000,000 share issuance.
- Assess the impact of the "substantial number of broker non-votes" on future capital raising efforts.